| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGAGCAGCUGGCAGCGCGGCGGGCAGCGUUUGCCGAGCGGGCGCUCCGG… | 3898 nt | 0.5575 | |
| GCAGGGGUGCCAUCUUGGCUCACUGCAACCUCCGCCUCAUGGGUUCAAG… | 4309 nt | 0.5456 | |
| GUGGGCUCGCUGGCGCGACCCGCGCGGGCCAGUGGGAGUGCGGGAGGGA… | 3846 nt | 0.5554 | |
| UGGGCACCGAGGGGUCCCGGGGUCCGCGGAUCUCGGGUGGGGUUUUUCC… | 3871 nt | 0.5528 | |
| UGGGCACCGAGGGGUCCCGGGGUCCGCGGAUCUCGGGUGGGGUUUUUCC… | 4252 nt | 0.5489 |
This gene encodes a member of a subfamily of RING-finger type E3 ubiquitin ligases. The protein binds to specific DNA sequences, and recruits a histone deacetylase to regulate gene expression. Its expression peaks at late G1 phase and continues during G2 and M phases of the cell cycle. It plays a major role in the G1/S transition by regulating topoisomerase IIalpha and retinoblastoma gene expression, and functions in the p53-dependent DNA damage checkpoint. It is regarded as a hub protein for the integration of epigenetic information. This gene is up-regulated in various cancers, and it is therefore considered to be a therapeutic target. Multiple transcript variants encoding different isoforms have been found for this gene. A related pseudogene exists on chromosome 12. [provided by RefSeq, Feb 2014]
No relevant information is available at the moment.